A pilot phase II study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA.

Authors

Publication/Presentation Date

5-2013

Volume

31

Issue

15

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS